Investors
Horizon investors are venture capital firms specializing in the healthcare and life sciences fields. The Company has raised $51Million in private financing through Scale Venture Partners (formerly BA Venture Partners), Pequot Ventures, Sutter Hill Ventures, and Essex Woodlands Health Ventures.
Scale Venture Partners (formerly BA Venture Partners) employs a thesis-based strategy to identify innovative development-stage technology and healthcare investments in emerging markets. Based in Foster City, California, the Scale team collectively offers decades of technology and venture industry experience to development-stage companies in hardware, software, healthcare and medical devices. Representative portfolio companies include Ascenta, Diadexus, Seattle Genetics (NASDAQ: SGEN), Somaxon (NASDAQ: SOMX), SGX Pharmaceuticals (NASDAQ: SGXP), Cellective Therapeutics (Acq by Medimmune), Dynavax (NASDAQ: DVAX), Orexigen, and Zogenix.
With more than $1.8 billion in capital commitments, Pequot Ventures is the venture investing arm of Pequot Capital Management, one of the oldest and largest, multi-billion dollar alternative asset management companies worldwide. Pequot Ventures is a venture capital firm focusing on biotechnology platform companies that speed up the drug research process and have a business model that allows the companies to benefit from therapeutic breakthroughs over the longer term. Life Sciences Companies backed by Pequot include Codexis, Threshold Pharmaceuticals, Sequenom, Prestwick, Insulet, Embolic Protection and Cryovascular Systems, among others.
Sutter Hill Ventures is a venture capital firm that finances technology-based start-up and early stage companies pioneering products or services in growth markets, especially those in information technology and health care. Founded in 1962, it is one of Silicon Valley's original venture capital firms. Companies backed by Sutter Hill include nVidia, Amylin Pharmaceuticals, COR Therapeutics, Corixa, Portola Pharmaceuticals, Threshold Pharmaceuticals, and Lifescan.
Essex Woodlands Health Ventures (with roughly $1.6 billion under management) is one of the world's premier venture capital firms focused exclusively on the healthcare industry. Essex Woodlands recently raised their seventh fund of $600 million. The firm has offices in California, Texas, New York and London. The Essex Woodlands team has been involved in the founding, investing, and/or management of over 100 healthcare companies ranging across all sectors, stages and geography.